INTERISE TRUST has informed the Exchange regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026-27

TRUST October 16, 2026 Corporate Relations Department The Listing Department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 Scrip Code: 541300 | 977222 | 977223 | 978247 Trading Symbol: INTERISE | 978248 | 978249 Dear Sir/Madam, Sub: Quarterly Compliance Report on Corporate Governance of Interise Trust We hereby inform that pursuant to Regulation 26K of the SEBI (Infrastructure Investment Trusts) Regulations, 2014) read with SEBI Master circular no. SEBI/HO/DDHS-PoD- 2/P/CIR/2025/102 dated July 11, 2025, as amended from time to time, we hereby submit the Compliance Report on Corporate Governance (Part A) for Interise Trust for the quarter ended September 30, 2026. You are requested to take the same on your record. Thank you. Yours Truly, For Interise Trust Through its Investment Manager, Interise Investment Managers Private Limited Amit Shah Chief Compliance Officer & Vice President - Company Secretary Trustee to Interise Debenture Trustee ICICI Bank Limited, IDBI Trusteeship Services Limited Axis Trustee Services Limited Issuer and Paying Agent, ICICI 4th Floor, Office No. 405, The Ruby, 2nd Floor, SW, 29 Bank Ltd, L&T Ltd., Mount Kanchenjunga Building, Barakhamba Senapati Bapat Marg, Poonamallee Rd, Manapakkam, Road, New Delhi – 110001 Dadar West, Mumbai - 400 028 Chennai – 600089 SEBI Regn. No. IN/InvIT/17-18/0007 Principal Place of Business: A-303 & 304, 3rd Floor, Delphi Orchard Avenue, Hiranandani Business Park, Powai, Mumbai - 400076 | Tel: +91 22 3507 1500 • E-mail: investor.cs@interiseworld.com • Website: www.interiseworld.com Quarterly Compliance Report on Governance Annexure – 15 Part A [Chapter 20 of SEBI Master Circular No. SEBI/HO/DDHS-PoD-2/P/CIR/2025/102 dated July 11, 2025 (‘Master Circular’)] 1. Name of InvIT Interise Trust (‘Trust’ or ‘InvIT’, unless the context requires otherwise) 2. Registration No IN/InvIT/17-18/0007 3. Name of the Investment Manager Interise Investment Managers Private Limited 4. Quarter ending September 30, 2026 I. Composition of Board of Directors of the Investment Manager Title Name DIN Category Initial Date of Date of Tenure* No. of No of Number of Number of posts of (Mr. / of the Director (Chairperson Date of Reappointment Cessation (months) directorships Independent memberships in Chairperson in Audit / Ms.) / Non-Independent / Appointment in all directorships Audit / Stakeholder Stakeholder Independent / Managers / in all Committee(s) in all Committee(s) in all Nominee)& Investment Managers / Managers / Managers / Investment Managers of Investment Investment Managers of REIT / InvIT REIT / InvIT Managers of Managers of REIT / and listed entities, and listed REIT / InvIT InvIT and listed including this entities, and listed entities, including Investment Manager including this entities, this Investment (Refer Regulation 26G Investment including this Manager of InvIT Regulations) Manager Investment (Refer Regulation Manager 26G of InvIT Regulations) Ms. Neera Saggi 00501029 Chairperson- 24-03-2021 24-03-2026 - 66 4 4 6 1 Independent Director Mr. Sudhakar Mallya 10372145 Nominee Director 07-11-2023 - - - 1 0 2 0 (Unitholder) Mr. Julian Gratiaen 10741241 Nominee Director 10-02-2026 - - 1 0 2 0 (Unitholder) Ms. Monisha 00144660 Independent 28-06-2018 28-06-2023 - 99 1 1 2 0 Macedo Director Ms. Samyuktha 07138327 Independent 24-08-2017 24-08-2022 - 109 1 1 1 0 Surendran Director Mr. Sanjay Ubale 02040738 Independent 29-03-2023 - - 42 1 1 2 1 Director Mr. Ravindran 09778966 Independent 27-06-2023 - - 39 2 2 4 2 Shunmugakani Director $PAN of any director would not be displayed on the website of Stock Exchange. &Category of directors means non-independent/independent/Nominee. If a director fits into more than one category write all categories separating them with hyphen. *to be filled only for Independent Director. Tenure would mean total period from which Independent director is serving on Board of directors of the investment manager in continuity without any cooling off period. Whether Regular chairperson appointed Yes Whether Chairperson is related to managing director or CEO No II. Composition of Committees Name of Committee Whether Name of Committee members Category Date of Date of Regular (Chairperson/Non- Appointment Cessation chairperson Independent/Independent appointed /Nominee) & 1. Audit Committee Yes Mr. Ravindran Shunmugakani Chairman- Independent Director 27-06-2023 Mr. Sudhakar Mallya Nominee Director (Unitholder) 07-11-2023 Ms. Samyuktha Surendran Independent Director 17-10-2018 Ms. Neera Saggi Independent Director 14-07-2021 Mr. Sanjay Ubale Independent Director 29-03-2023 Ms. Monisha Macedo Independent Director 28-06-2018 Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 2. Nomination & Remuneration Committee Yes Ms. Samyuktha Surendran Chairperson- Independent Director 17-10-2018 Ms. Monisha Macedo Independent Director 28-06-2018 Ms. Neera Saggi Independent Director 29-03-2023 Mr. Sanjay Ubale Independent Director 29-03-2023 Mr. Ravindran Shunmugakani Independent Director 27-06-2023 Mr. Sudhakar Mallya Nominee Director (Unitholder) 06-05-2025 Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 3. Risk Management Committee Yes Ms. Monisha Macedo Chairperson- Independent Director 01-12-2022 Mr. Sudhakar Mallya Nominee Director (Unitholder) 07-11-2023 Ms. Samyuktha Surendran Independent Director 11-01-2022 Ms. Neera Saggi Independent Director 11-01-2022 Mr. Ravindran Shunmugakani Independent Director 01-04-2025 Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 4. Stakeholders Relationship Committee (in Mr. Sanjay Ubale Chairperson- Independent Director 28-06-2023 our case, known as Stakeholders Yes Mr. Sudhakar Mallya Nominee Director (Unitholder) 07-11-2023 Relationship and Investor Relations and Ms. Monisha Macedo Independent Director 28-06-2018 Grievance Committee) Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 5. Investment and Finance Committee Yes Mr. Sanjay Ubale Chairperson- Independent Director 28-06-2023 Mr. Sudhakar Mallya Nominee Director (Unitholder) 07-11-2023 Name of Committee Whether Name of Committee members Category Date of Date of Regular (Chairperson/Non- Appointment Cessation chairperson Independent/Independent appointed /Nominee) & Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 Mr. Pawan Kant Member – Chief Executive Officer 20-05-2021 6. Projects Review Committee Yes Mr. Sanjay Ubale Chairperson- Independent Director 01-04-2025 Mr. Sudhakar Mallya Nominee Director (Unitholder) 07-11-2023 Ms. Monisha Macedo Member- Independent Director 11-01-2022 Ms. Samyuktha Surendran Member- Independent Director 11-01-2022 Ms. Neera Saggi Member- Independent Director 11-01-2022 Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 7. Corporate Social Responsibility Yes Ms. Monisha Macedo Chairperson- Independent Director 19-07-2022 Committee Mr. Sudhakar Mallya Nominee Director (Unitholder) 07-11-2023 Mr. Julian Gratiaen Nominee Director (Unitholder) 10-02-2026 & Category of directors means non-independent/independent/Nominee. If a director fits into more than one category write all categories separating them with hyphen. III. Meetings of Board of Directors Date(s) of Date(s) of Whether Number of Directors Number of Maximum gap Meeting (if any) Meeting (if any) requirement of present* independent between any two in the previous in the relevant Quorum met* directors present* consecutive meetings quarter quarter (in number of days) 28-04-2026 Yes 7 5 - 02-06-2026 Yes 7 5 34 days 29-06-2026 Yes 7 5 26 days 12-08-2026 Yes 7 5 44 days * to be filled in only for the current quarter meetings IV. Meetings of Committees Date(s) of Whether Number of Number of Date(s) of meeting of Maximum gap meeting of the requirement of Directors independent the committee in the between any two commi [Showing first 8,000 characters — download PDF for full document]